nematode anticoagulant protein c2
Animal productexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2005 (NCT00116012)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nematode anticoagulant protein c2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00443573 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2006 | Arca Biopharma, Inc. |
| NCT00116012 | Phase 2 | Jun 1, 2005 | Arca Biopharma, Inc., The TIMI Study Group |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arca Biopharma, Inc. | For profit | 2 | 2 | 1 | 2005 |
| The TIMI Study Group | Academic/Hospital | 1 | 0 | 1 | 2005 |
2 organizations
Page 1 / 1